Taken together, our own result and these findings in literature indicate that plasma tau is a late marker of neurodegeneration, requiring substantial injury before increasing to abnormal levels at the transition from MCI to dementia stage of AD. This evidence concerns the gene MAPT and Alzheimer disease.